PeptiDream Inc. (TSE: 4587)
Health Care · Biotechnology · JP
¥1,075.00
+2.14% today · -34.9% 1Y
PeptiDream Inc. (TSE: 4587) operates in the Biotechnology industry within the Health Care sector. The company is valued at $872.86M and employs 763 people.
Over the last twelve months the share price has lost 34.9%, trading between 906.40 and 1.79K.
Tweenvest scores PeptiDream Inc. across four factors: quality 87/100, value 81/100. Its strongest factor is quality.
4587 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $872.86M
- Revenue (TTM)
- $118.15M
- P/E
- —
- EPS
- -28.10
- Dividend yield
- —
- Beta (5Y)
- 0.15
- 52-week high
- ¥1,793.00
- 52-week low
- ¥906.40
- Avg volume (3M)
- —
- Shares outstanding
- 128.57M
- Employees
- 763
- Next earnings
- —
About PeptiDream Inc.
PeptiDream Inc. functions as a biopharmaceutical enterprise, concentrating on the identification and progression of therapeutic compounds such as constrained peptides, small molecules, and peptide-drug conjugates. The company's unique product pipeline is underpinned by its proprietary Peptide Discovery Platform System (PDPS), an advanced technology specifically designed for the development of peptide-based drugs. Additionally, PeptiDream maintains an exclusive licensing and collaborative research partnership with Takeda Pharmaceutical Company Limited, aimed at creating peptide drug conjugates for the treatment of neuromuscular conditions. Established in 2006, the company's primary offices are situated in Kawasaki, Japan.
- ISIN
- JP3836750004
- Founded
- 2006
- Listed since
- Jun 12, 2013
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Beijing SL Pharmaceutical Co., Ltd.SZSE: 002038 | $883.46M | CN¥5.76 | +0.17% |
| Monte Rosa Therapeutics, Inc.NasdaqGS: GLUE | $878.73M | $10.30 | -0.19% |
| Lepu Biopharma Co., Ltd.SEHK: 2157 | $878.35M | HK$3.82 | -5.56% |
| Kuros Biosciences AGSWX: KURN | $878.10M | CHF18.35 | -1.50% |
| Hangzhou Biotest Biotech Co.,Ltd.SHSE: 688767 | $865.08M | CN¥39.60 | -1.49% |
| Sana Biotechnology, Inc.NasdaqGS: SANA | $835.22M | $2.79 | 0.00% |
| Arbutus Biopharma CorporationNasdaqGS: ABUS | $834.92M | $4.22 | +0.96% |
| Oxford Biomedica plcLSE: OXB | $834.48M | £5.21 | -4.23% |
Figures last refreshed Oct 11, 2026.